{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:19:59Z","timestamp":1791425999843,"version":"4.3.3"},"reference-count":101,"publisher":"Microbiology Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,1]]},"abstract":"<jats:p>Poliovirus causes paralytic poliomyelitis, an ancient disease of humans that became a major public-health issue in the 20th century. The primary site of infection is the gut, where virus replication is entirely harmless; the two very effective vaccines developed in the 1950s (oral polio vaccine, or OPV, and inactivated polio vaccine, or IPV) induce humoral immunity, which prevents viraemic spread and disease. The success of vaccination in middle-income and developing countries encouraged the World Health Organization to commit itself to an eradication programme, which has made great advances. The features of the infection, including its largely silent nature and the ability of the live vaccine (OPV) to evolve and change in vaccine recipients and their contacts, make eradication particularly challenging. Understanding the pathogenesis and virology of the infection is of major significance as the programme reaches its conclusion.<\/jats:p>","DOI":"10.1099\/vir.0.036988-0","type":"journal-article","created":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T15:33:07Z","timestamp":1322753587000},"page":"457-474","source":"Crossref","is-referenced-by-count":58,"title":["The polio-eradication programme and issues of the end game"],"prefix":"10.1099","volume":"93","author":[{"given":"Philip D.","family":"Minor","sequence":"first","affiliation":[{"name":"National Institute of Biological Standards and Control, Health Protection Agency, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"r1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.5.1105"},{"key":"r2","first-page":"43","article-title":"Some problems of molecular biology of poliovirus infection relevant to pathogenesis, viral spread and evolution","volume":"105","author":"Agol","year":"2001","journal-title":"Dev Biol (Basel)"},{"key":"r3","doi-asserted-by":"publisher","DOI":"10.1126\/science.1124959"},{"key":"r4","doi-asserted-by":"publisher","DOI":"10.1126\/science.122.3159.105"},{"key":"r5","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/JVI.69.8.4972-4978.1995","article-title":"Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine","volume":"69","author":"Bouchard","year":"1995","journal-title":"J Virol"},{"key":"r6","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.7.3259-3272.2006"},{"key":"r7","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00508-09"},{"key":"r8","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.18974-0"},{"key":"r9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0042-6822(88)90113-4","article-title":"Intertypic genomic rearrangements of poliovirus strains in vaccinees","volume":"167","author":"Cammack","year":"1988","journal-title":"Virology"},{"key":"r10","first-page":"1002","article-title":"Update on vaccine-derived polioviruses \u2013 worldwide, January 2008\u2013June 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"r11","first-page":"846","article-title":"Update on vaccine-derived polioviruses \u2013 worldwide, July 2009\u2013March 2011","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"r12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1633511100"},{"key":"r13","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1769"},{"key":"r14","doi-asserted-by":"publisher","DOI":"10.1126\/science.1155761"},{"key":"r15","first-page":"217","article-title":"Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003","volume":"118","author":"Deshpande","year":"2003","journal-title":"Indian J Med Res"},{"key":"r16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008677"},{"key":"r17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2006.03.003"},{"key":"r18","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1996.0010"},{"key":"r19","doi-asserted-by":"publisher","DOI":"10.1086\/424524"},{"key":"r20","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890320205"},{"key":"r21","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg202"},{"key":"r22","doi-asserted-by":"publisher","DOI":"10.1038\/314548a0"},{"key":"r23","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.6.1291"},{"key":"r24","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/j.1460-2075.1989.tb03541.x","article-title":"Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus","volume":"8","author":"Filman","year":"1989","journal-title":"EMBO J"},{"key":"r25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a009924","article-title":"Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative","volume":"150","author":"Fine","year":"1999","journal-title":"Am J Epidemiol"},{"key":"r26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60531-5"},{"key":"r27","first-page":"3","article-title":"Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom","volume":"82","author":"Halsey","year":"2004","journal-title":"Bull World Health Organ"},{"key":"r28","first-page":"1272","article-title":"Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses","volume":"151","author":"Hammon","year":"1953","journal-title":"J Am Med Assoc"},{"key":"r29","doi-asserted-by":"publisher","DOI":"10.1126\/science.2994218"},{"key":"r30","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2358"},{"key":"r31","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.8.1.5"},{"key":"r32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02354-07"},{"key":"r33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.4.412"},{"key":"r34","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068284"},{"key":"r35","volume-title":"Splendid Solution: Jonas Salk and the Conquest of Polio","author":"Kluger","year":"2004"},{"key":"r36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.3.951"},{"key":"r37","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.23.12460-12465.2003"},{"key":"r38","doi-asserted-by":"publisher","DOI":"10.1086\/503366"},{"key":"r39","first-page":"377","article-title":"\u00dcbertragung der Poliomyelitis acuta auf Affen","volume":"2","author":"Landsteiner","year":"1909","journal-title":"Z Immunitaetsforsch Exp Ther"},{"key":"r40","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.Supplement_2.S457"},{"key":"r41","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.19.10423-10431.2003"},{"key":"r42","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1128\/JVI.65.10.5225-5231.1991","article-title":"An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain","volume":"65","author":"Macadam","year":"1991","journal-title":"J Virol"},{"key":"r43","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(92)90565-7"},{"key":"r44","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00370-06"},{"key":"r45","first-page":"72","article-title":"Hypogammaglobulinaemia in the United Kingdom. VII. The role of humoral antibodies in protection against and recovery from bacterial and virus infections in hypogammaglobulinaemia","volume":"310","author":"MacCallum","year":"1971","journal-title":"Spec Rep Ser Med Res Counc (G B)"},{"key":"r46","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16150-3"},{"key":"r47","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1128\/JCM.37.6.1670-1675.1999","article-title":"Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority","volume":"37","author":"Manor","year":"1999","journal-title":"J Clin Microbiol"},{"key":"r48","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2000.0614"},{"key":"r49","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.7.3001-3010.2000"},{"key":"r50","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19088-0"},{"key":"r51","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.24.13839-13847.2004"},{"key":"r52","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyg185"},{"key":"r53","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1128\/JVI.69.12.7601-7605.1995","article-title":"Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus","volume":"69","author":"McGoldrick","year":"1995","journal-title":"J Virol"},{"key":"r54","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90690-9"},{"key":"r55","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-59-2-307"},{"key":"r56","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-73-12-3065"},{"key":"r57","first-page":"555","article-title":"Poliovirus","volume-title":"Viral Pathogenesis","author":"Minor","year":"1997a"},{"key":"r58","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)85582-X"},{"key":"r59","doi-asserted-by":"publisher","DOI":"10.1038\/299109a0"},{"key":"r60","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-67-4-693"},{"key":"r61","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-70-5-1117"},{"key":"r62","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20250"},{"key":"r63","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00738-06"},{"key":"r64","doi-asserted-by":"publisher","DOI":"10.1086\/514081"},{"key":"r65","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.Supplement_2.S308"},{"key":"r66","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(08)00001-8"},{"key":"r67","doi-asserted-by":"publisher","DOI":"10.1001\/jama.257.10.1335"},{"key":"r68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.19.5793"},{"key":"r69","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(81)90448-7"},{"key":"r70","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.Supplement_2.S318"},{"key":"r71","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02675-06"},{"key":"r72","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/JVI.58.2.348-358.1986","article-title":"Genetic analysis of the attenuation phenotype of poliovirus type 1","volume":"58","author":"Omata","year":"1986","journal-title":"J Virol"},{"key":"r73","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92091-5"},{"key":"r74","volume-title":"A History of Poliomyelitis","author":"Paul","year":"1971"},{"key":"r75","doi-asserted-by":"publisher","DOI":"10.1038\/334320a0"},{"key":"r76","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1128\/JVI.63.11.4949-4951.1989","article-title":"Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine","volume":"63","author":"Pollard","year":"1989","journal-title":"J Virol"},{"key":"r77","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/AEM.54.2.371-374.1988","article-title":"Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland","volume":"54","author":"P\u00f6yry","year":"1988","journal-title":"Appl Environ Microbiol"},{"key":"r78","doi-asserted-by":"publisher","DOI":"10.1126\/science.6272391"},{"key":"r79","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90168-E"},{"key":"r80","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(87)90001-8"},{"key":"r81","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2000.0244"},{"key":"r82","doi-asserted-by":"publisher","DOI":"10.1126\/science.123.3209.1151"},{"key":"r83","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6519.531"},{"key":"r84","doi-asserted-by":"publisher","DOI":"10.1016\/0092-1157(73)90048-6"},{"key":"r85","doi-asserted-by":"publisher","DOI":"10.1007\/BF00917895"},{"key":"r86","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2008.07.006"},{"key":"r87","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1128\/JCM.38.10.3729-3734.2000","article-title":"Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel","volume":"38","author":"Shulman","year":"2000","journal-title":"J Clin Microbiol"},{"key":"r88","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2006.02.010"},{"key":"r89","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(90)90190-3"},{"key":"r90","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.6.1510"},{"key":"r91","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00827.x"},{"key":"r92","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.04.001"},{"key":"r93","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60532-7"},{"key":"r94","doi-asserted-by":"publisher","DOI":"10.1038\/nature04388"},{"key":"r95","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.02.085"},{"key":"r96","article-title":"Global eradication of poliomyelitis by the year 2000 (World Health Assembly resolution WHA 41\u201328)","year":"1988"},{"key":"r97","article-title":"Poliomyelitis","year":"2011a"},{"key":"r98","article-title":"Reported estimates of immunization coverage time series","year":"2011b"},{"key":"r99","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-micro-090110-102957"},{"key":"r100","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.15.8366-8377.2003"},{"key":"r101","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.20.12623-12634.2005"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.036988-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T23:29:53Z","timestamp":1603754993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.036988-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3,1]]}},"URL":"https:\/\/doi.org\/10.1099\/vir.0.036988-0","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,1]]}}}